Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001596771-17-000059
Filing Date
2017-07-24
Accepted
2017-07-24 15:21:20
Documents
2
Period of Report
2017-07-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1575
2 POWER OF ATTORNEY poabachinski.txt EX-24 2992
  Complete submission text file 0001596771-17-000059.txt   6004
Mailing Address 24 TURNBERRY DRIVE WILLIAMSVILLE NY 14221
Business Address 24 TURNBERRY DRIVE WILLIAMSVILLE NY 14221 (708) 902-7450
NEUROONE MEDICAL TECHNOLOGIES Corp (Issuer) CIK: 0001500198 (see all company filings)

EIN.: 270863354 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 6794 Patent Owners & Lessors

Mailing Address 19059 ORCHARD TRAIL LAKEVILLE MN 55044
Business Address
Bachinski Thomas (Reporting) CIK: 0001710364 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54716 | Film No.: 17978255